Exicure Inc

NASDAQ:XCUR   3:59:43 PM EDT
0.16
-0.01 (-4.31%)
4:54:00 PM EDT: $0.16 0.00 (1.46%)
Layoffs, Products, Officer Changes

Exicure Inc Announces Results Of Internal Investigation

Published: 12/10/2021 22:39 GMT
Exicure Inc (XCUR) - Exicure, Inc. Announces Results of Internal Investigation and Implementation of Strategic Measures to Reduce Cash Burn and Prioritize Pipeline Focus.
Exicure Inc - Will Reduce Its Workforce by Approximately 50%, Along With the Implementation of Other Cost-cutting Measures.
Exicure Inc - Brian C. Bock Appointed President and Chief Executive Officer.
Exicure Inc - to Wind Down Immuno-oncology Program Cavrotolimod (ast-008) and Xcur-fxn Preclinical Program.
Exicure Inc - Expects to Realize About $6.0 Million in Employee Related Cost Savings in 2022.
Exicure Inc - Will Align Research and Development Resources to Support Development of Its Preclinical Programs Targeting Scn9a for Pain As Well As Its Partnered Programs.
Further Company Coverage: Xcuro